Delivery Order SPE2DB20D3103-SPE2DB21FQ4X9
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00, provides for the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials. The contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $30,660.08 for the supply of 4,564,235,925 units of Epinephrine 0.3 mg Auto-Injectors. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is a delivery order valued at $1,469.04 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the delivery of Epinephrine 0.15 mg auto-injectors, a critical medication used for the emergency treatment of severe allergic reactions. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to AmerisourceBergen Drug Corp is a firm-fixed-price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The award is for the supply of 4,562,800 units of 0.3 mg epinephrine auto-injectors, a critical medical product used for emergency treatment of severe allergic reactions. This delivery order, valued at $1,345.03, has a performance period through November 14, 2023. The...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Epinephrine 0.3 mg auto-injectors. The $5,602.21 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 28, 2021. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
- This contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The DO has a not-to-exceed value of $4,649.22 and covers the delivery of EPINEPHRINE 0.15 MG AUTO-INJCT 2S, a critical medication used for the emergency treatment of severe allergic reactions. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,429.48 Firm Fixed Price Delivery Order is for 4,560,941,986 units of Epinephrine 0.3 mg Auto-Inject with a completion date of May 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,248.51, is for the supply of EPINEPHRINE 0.15 MG AUTO-INJECTORS. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,794.36 for the supply of 4,560,191,097 units of Epinephrine 0.15 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 9, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award is a delivery order worth $3,704.42 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the procurement of epinephrine 0.3 mg auto-injectors. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ4X9Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The DO, valued at $2,780.55, is for the delivery of Epinephrine 0.3 mg Auto-Injector 2s, a critical pharmaceutical product used for emergency treatment of severe allergic reactions. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a major pharmaceutical distributor, Amerisourcebergen provides a wide range of medical commodities, including specialty medications, generic drugs, medical devices, and other supplies to support the healthcare needs of the U.S. military and veterans. This DO is part of Amerisourcebergen's extensive federal contracting portfolio, which includes several large IDCs with the DLA and the Department of Justice, demonstrating the company's ability to meet the diverse pharmaceutical requirements of multiple government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/28/21 |